All Non-tuberculous mycobacterium articles
-
NewsResearch finds vegan honey could be made with similar antimicrobial properties to mānuka honey
Vegan honey alternatives could be engineered to have similar antimicrobial properties to prized mānuka honey from New Zealand, according to research. Two components of mānuka honey proved to be particularly effective when added to vegan honey formulations - methylglyoxal (MGO) and hydrogen peroxide.
-
NewsCRISPR nanodroplet technology offers a new strategy for rapid, multiplexed, species-level identification of mycobacteria
In a new commentary, researchers discuss the clinical and technological potential of a CRISPR-assisted nanodroplet platform, highlighting its ability to combine broad-range amplification, species-specific CRISPR recognition, fluorescence encoding, and microfluidic droplet pairing within a single diagnostic architecture.
-
NewsNew test could dramatically speed diagnosis of hard-to-detect lung infections
Nontuberculous mycobacteria can cause chronic, tuberculosis-like lung infections. Researchers have developed a new diagnostic platform that can identify the precise species of bacteria causing a patient’s infection in just a few hours — a dramatic improvement over the current standard, which can take four to six weeks.
-
CareersMeet the Global Ambassadors: our Q&A with Sanjib Bhakta
The Microbiologist gets to know our Global Ambassador for the UK, Professor Sanjib Bhakta who is Professor of Molecular Microbiology and Biochemistry at Birkbeck, University of London.
-
NewsSteroids reduce inflammation in chronic mycobacterial lung infections without limiting antimicrobial defence
Researchers have shown that dexamethasone, a commonly prescribed anti-inflammatory steroid, can reduce harmful inflammation triggered by Mycobacterium avium without weakening the ability of human immune cells to control the infection.
-
NewsBronchiectasis and NTM Research Registry data featured in four World Bronchiectasis Conference abstracts
The Bronchiectasis and NTM Association announced that research leveraging data from the Bronchiectasis and NTM Research Registry was featured in four abstracts presented at the World Bronchiectasis Conference.
-
NewsBronchiectasis and NTM Care Center Network expands to 62 centers
The Bronchiectasis and NTM Association has accepted one new Care Center and three new Clinical Associate Center sites into the Bronchiectasis and NTM Care Center Network (CCN). The CCN includes 62 centers across the United States.
-
NewsResearchers advance phage therapy in fight against antimicrobial resistance
Scientists have uncovered how Mycobacterium abscessus can evade bacteriophage therapy, and demonstrated a combination strategy to overcome this resistance, offering a pathway towards more effective and durable treatments.
-
NewsCDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
-
NewsBlood test using artificial intelligence paves the way for early diagnosis of leprosy
A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. The method showed potential for identifying the disease in its initial stages, when symptoms are subtle and traditional laboratory tests often fail.
-
NewsResearchers develop new inhalable treatment for TB
Researchers have developed an inhalable, immunomodulating, biocompatible nanoparticle system encapsulating rifampin, one of the most important TB drugs.
-
NewsSkin test reagent proves effective and safe for TB diagnosis in children
A new class of skin test reagents based on Mycobacterium tuberculosis (MTB)-specific antigens has been developed. A phase III clinical trial suggests that C-TST is an effective and safe option for diagnosing pediatric TBI.
-
FeaturesTap water troubles: how drinking water systems contribute to NTM infections
Commonly found in dust and soil, NTM are worrying microbiologists and health experts alike. But is tap water an unsuspected vehicle for these deceptively harmful infections?
-
NewsGeneXpert MTB/RIF technology can distinguish non-tuberculous mycobacterial infection
Xpert Mycobacterium tuberculosis/rifampicin (Xpert MTB/RIF) in alveolar lavage fluid can not only detect rifampicin resistance but also distinguish pulmonary tuberculosis (TB) from non-tuberculosis mycobacterial (NTM) pulmonary disease.
-
NewsUncovered: A long-lasting history of leprosy in the Americas
A new study challenges the view that leprosy is a disease that was introduced into the Americas during European colonization. A strain of leprosy-causing mycobacterium, Mycobacterium lepromatosis, infected humans in the Americas before European contact.
-
NewsScientists introduce new engineered drug candidate for Mycobacterium abscessus to save lives
Scientists have introduced a promising drug candidate engineered to target a deadly and emerging infection. They took a hyper-detailed look into the problem of Mycobacterium abscessus, and chemically re-engineered a widely-used rifamycin antibiotic.
-
NewsAdd some spice: Curcumin helps treat Mycobacterium abscessus
Researchers have found that adding curcumin boosts the efficacy of bedaquiline, an antimycobacterial used to treat tuberculosis, in combating M. abscessus infections. Curcumin is the compound that gives turmeric its characteristic bright orange color.
-
NewsA*STAR spin-off NalaGenetics implements nationwide drug reaction screening for leprosy patients in Indonesia
NalaGenetics, a spin-off from A*STAR Genome Institute of Singapore (A*STAR GIS), will be transforming leprosy treatments in Indonesia with a nationwide genetic screening programme with their PGx1301 diagnostic kit.
-
NewsTailored guidelines and reduced stigma needed to tackle leprosy, Irish case study reveals
A case report on an adult with an imported case of leprosy in Ireland shows that there are notable challenges in tackling the disease in settings where it is rare. The affected individual was one of five individuals with leprosy reported in Ireland in the past decade.
-
NewsJordan becomes first country to receive WHO verification for eliminating leprosy
The World Health Organization (WHO) has congratulated the Hashemite Kingdom of Jordan for becoming the first country in the world to be officially verified as having eliminated leprosy.